Compare GDHG & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDHG | EVGN |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 10.9M |
| IPO Year | 2023 | N/A |
| Metric | GDHG | EVGN |
|---|---|---|
| Price | $2.81 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 16.7K | ★ 47.7K |
| Earning Date | 07-11-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,666,899.00 | $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $2.40 | $0.95 |
| 52 Week High | $1,968.41 | $2.42 |
| Indicator | GDHG | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 26.00 | 39.65 |
| Support Level | $2.56 | $1.07 |
| Resistance Level | $4.50 | $1.12 |
| Average True Range (ATR) | 0.46 | 0.05 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 12.71 | 23.68 |
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.